These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9345465)

  • 1. Transient immunomodulation by intravenous methylprednisolone treatment of multiple sclerosis.
    Crockard AD; Treacy MT; Droogan AG; McNeill TA; Hawkins SA
    Mult Scler; 1995 Apr; 1(1):20-4. PubMed ID: 9345465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4 subsets (CD45RA/RO) exhibit differences in proliferative responses, IL-2 and gamma-interferon production during intravenous methylprednisolone treatment of multiple sclerosis.
    Crockard AD; Treacy MT; Droogan AG; Hawkins SA
    J Neurol; 1996 Jun; 243(6):475-81. PubMed ID: 8803822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of immunomodulatory treatment of multiple sclerosis on lymphocyte surface immunomarkers.
    Michałowska-Wender G; Losy J; Wender M; Januszkiewicz-Lewandowska D; Nowak J
    Pol J Pharmacol; 2003; 55(5):877-80. PubMed ID: 14704481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-course analysis of CD25 and HLA-DR expression on lymphocytes in interferon-beta 1b-treated multiple sclerosis patients.
    Ferrarini AM; Sivieri S; Buttarello M; Facchinetti A; Perini P; Gallo P
    Mult Scler; 1998 Jun; 4(3):174-7. PubMed ID: 9762669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylprednisolone attenuates interferon-beta induced expression of HLA-DR on monocytes.
    Crockard AD; Treacy MT; Droogan AG; Hawkins SA
    J Neuroimmunol; 1996 Oct; 70(1):29-35. PubMed ID: 8862132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with methylprednisolone in relapses of multiple sclerosis patients: immunological evidence of immediate and short-term but not long-lasting effects.
    Martínez-Cáceres EM; Barrau MA; Brieva L; Espejo C; Barberà N; Montalban X
    Clin Exp Immunol; 2002 Jan; 127(1):165-71. PubMed ID: 11882048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytokine-secreting cells in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisolone].
    Yagi Y; Takahashi M; Nakamura Y
    Rinsho Shinkeigaku; 1997 Jul; 37(7):575-9. PubMed ID: 9396353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating dendritic cells subsets and regulatory T-cells at multiple sclerosis relapse: differential short-term changes on corticosteroids therapy.
    Navarro J; Aristimuño C; Sánchez-Ramón S; Vigil D; Martínez-Ginés ML; Fernández-Cruz E; de Andrés C
    J Neuroimmunol; 2006 Jul; 176(1-2):153-61. PubMed ID: 16698092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of integrins on activated T-cells in multiple sclerosis. Effect of intravenous methylprednisolone treatment.
    Luján S; Masjuan J; Roldán E; Villar LM; González-Porqué P; Alvarez-Cermeño JC
    Mult Scler; 1998 Jun; 4(3):239-42. PubMed ID: 9762681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar biological effect of high-dose oral versus intravenous methylprednisolone in multiple sclerosis relapses.
    Grau-López L; Teniente-Serra A; Tintoré M; Rovira A; Ramió-Torrenta L; Brieva L; Saiz A; Cano A; Carmona O; Hervás JV; Martínez-Cáceres EM; Ramo-Tello C
    Mult Scler; 2015 Apr; 21(5):646-50. PubMed ID: 25145693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes.
    Leussink VI; Jung S; Merschdorf U; Toyka KV; Gold R
    Arch Neurol; 2001 Jan; 58(1):91-7. PubMed ID: 11176941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis.
    Richert ND; Ostuni JL; Bash CN; Leist TP; McFarland HF; Frank JA
    Mult Scler; 2001 Feb; 7(1):49-58. PubMed ID: 11321194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of oral versus intravenous methylprednisolone regimens on peripheral blood T lymphocyte adhesion molecule expression, T cell subsets distribution and TNF alpha concentrations in multiple sclerosis.
    Pitzalis C; Sharrack B; Gray IA; Lee A; Hughes RA
    J Neuroimmunol; 1997 Apr; 74(1-2):62-8. PubMed ID: 9119980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is interferon gamma suppression after cardiac surgery caused by a decreased interleukin-12 synthesis?
    Franke A; Lante W; Kurig E; Zöller LG; Weinhold C; Markewitz A
    Ann Thorac Surg; 2006 Jul; 82(1):103-9. PubMed ID: 16798198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment].
    Bongioanni P; Romano MR; Boccardi B; Lombardo F; Moscato G; Mosti S; Baldini C; Nuti S; Meucci G; Rossi B
    Rev Neurol; 1999 Nov 16-30; 29(10):893-9. PubMed ID: 10637835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroid-depending effects on peripheral immune cell subsets vary according to disease modifying strategies in multiple sclerosis.
    Höpner L; Proschmann U; Inojosa H; Ziemssen T; Akgün K
    Front Immunol; 2024; 15():1404316. PubMed ID: 38938576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose methylprednisolone treatment-induced changes in immunological parameters in progressive MS patients.
    Dufour A; Salmaggi A; La Mantia L; Eoli M; Nespolo A; Milanese C
    Int J Neurosci; 1994 Mar; 75(1-2):119-28. PubMed ID: 7914185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis: expression of CD1a and production of IL-12p70 and IFN-gamma by blood mononuclear cells in patients on combination therapy with IFN-beta and glatiramer acetate compared to monotherapy with IFN-beta.
    Hussien Y; Sanna A; Söderström M; Link H; Huang YM
    Mult Scler; 2004 Feb; 10(1):16-25. PubMed ID: 14760948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylprednisolone treatment, immune activation, and intrathecal inflammation in multiple sclerosis.
    Sellebjerg F
    Dan Med Bull; 2004 May; 51(2):167-83. PubMed ID: 16009055
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.